Genmab — Januar 2016
-
Tisotumab - haha
-
-
Lundbeck er stadig på med partnerskab - og Gilead må være den hemmelige partner, siden de er eneste "nye" element under partnerskaberne
-
lyder sandsynligt - det virker temmelig udramatisk
-
vi starter vist med 1% skæve
-
Hvad går Genmabs samarbejde ud på med Ligand?http://www.genengnews.com/gen-news-highlights/ligand-to-acquire-omt-for-178-million/81252120/
-
det er vist hentet fra denne - http://www.bloomberg.com/news/articles/2016-01-06/drugs-join-danish-design-degustation-as-hot-commodities-chart
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind